A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 ...

Demis Hassabis of Google DeepMind predicts AI can end all diseases soon. He says AI can drastically cut drug development time ...

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging advanced algorithms to expedite drug discovery and development ... By ...

Nobel laureate and DeepMind CEO Demis Hassabis envisions a future where AI revolutionizes healthcare by drastically accelerating drug development—from years to weeks—and potentially curing all ...

A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced ... in biology with Exscientia’s focus on chemistry. Cody Powers, a life sciences ...